Philicon Pharmaceuticals
Producer of canned fruits, vegetables, and beverages
About Philicon Pharmaceuticals
Philicon-97 S.A. is a Bulgarian food and beverage company with a history spanning over 70 years. The company specializes in the production of fruit and vegetable products, including canned goods, juices, nectars, and drinks. Its product line features a wide variety of tomato-based items like sauces, ketchup, and purees, as well as traditional Bulgarian spreads such as lutenitsa. Philicon markets its products under several brands and is a prominent player in the local market.
Operating from Plovdiv, Bulgaria, the family-owned company emphasizes the use of ecologically clean fruits and vegetables to ensure product quality. Its manufacturing processes are certified by ISO 22000, IFS, and KOSHER standards. Philicon has a significant international presence, exporting its products to over 40 countries worldwide.
The company's business model is centered on producing and distributing a diverse portfolio of food and beverage products to both domestic and international markets. It serves consumers through retail channels, leveraging its long-standing brand recognition and reputation for quality.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Nanjing City, China
- Open positions
- None listed
- Dealroom signal
- 14.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2025 | $14M | $55M | Undisclosed | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Philicon Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Philicon Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







